Previous Article | Next Article 
Journal of Virology, June 2002, p. 5540-5547, Vol. 76, No. 11
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.11.5540-5547.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Isolation and Analysis of Retroviral Integration Targets by Solo Long Terminal Repeat Inverse PCR
Yi Feng Jin,1 Toshio Ishibashi,2 Akio Nomoto,1 and Michiaki Masuda1,3*
Department of Microbiology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033,1
Department of Otolaryngology, Social Insurance Central General Hospital, Tokyo 169-0073,2
Department of Microbiology, School of Medicine, Dokkyo University, Tochigi 321-0293, Japan3
Received 5 July 2001/
Accepted 4 February 2002

ABSTRACT
Upon retroviral infection, the genomic RNA is reverse transcribed
to make proviral DNA, which is then integrated into the host
chromosome. Although the viral elements required for successful
integration have been extensively characterized, little is known
about the host DNA structure constituting preferred targets
for proviral integration. In order to elucidate the mechanism
for the target selection, comparison of host DNA sequences at
proviral integration sites may be useful. To achieve simultaneous
analysis of the upstream and downstream host DNA sequences flanking
each proviral integration site, a Moloney murine leukemia virus-based
retroviral vector was designed so that its integrated provirus
could be removed by Cre-
loxP homologous recombination, leaving
a solo long terminal repeat (LTR). Taking advantage of the solo
LTR, inverse PCR was carried out to amplify both the upstream
and downstream cellular flanking DNA. The method called solo
LTR inverse PCR, or SLIP, proved useful for simultaneously cloning
the upstream and downstream flanking sequences of individual
proviral integration sites from the polyclonal population of
cells harboring provirus at different chromosomal sites. By
the SLIP method, nucleotide sequences corresponding to 38 independent
proviral integration targets were determined and, interestingly,
atypical virus-host DNA junction structures were found in more
than 20% of the cases. Characterization of retroviral integration
sites using the SLIP method may provide useful insights into
the mechanism for proviral integration and its target selection.

INTRODUCTION
The RNA genome of retroviruses is reverse transcribed into a
double-stranded DNA copy, which is then integrated into the
host chromosome as a provirus. Viral elements, such as integrase
(IN) and the terminal structures of viral DNA, that are required
for retroviral integration have been extensively characterized.
It has also been shown that selection of the proviral integration
targets is nonrandom (
15,
29-
31,
37,
47) and that the central
domain of IN plays a role in determining the target specificity
(
3,
36). The efficiency of chromosomal sites to become a preferred
integration target appears to be affected by several factors,
such as transcriptional activity (
35,
46), DNase I hypersensitivity
(
9,
32,
33,
45), methylation (
15), GC content (
5,
16,
34), nuclear
scaffold attachment (
20), nucleosome structure (
27,
28,
30,
31), and DNA structure of a higher order (
14,
22,
24,
27,
28).
However, these results were obtained by in vitro studies using
artificial target DNA or analysis of a small number of in vivo
integration sites, and it is still unclear why proviral integration
takes place at certain target sites more often than others.
To elucidate the mechanism of target selection for proviral
integration, it may be useful to compile and analyze a large
number of nucleotide sequences corresponding to proviral integration
sites in the context of actual cellular chromosome. Traditionally,
cellular flanking DNA of a provirus was cloned by the time-consuming
method of genomic library construction and screening. Although
the invention of PCR technology has led to rapid and simple
methods, such as inverse PCR (
40) and vectorette PCR (
2), those
techniques generally amplify either an upstream or downstream
flanking sequence at one time, but not both. Therefore, when
polyclonal populations of the cells harboring a provirus at
different chromosomal sites are analyzed, it is difficult to
tell which upstream sequence and downstream sequence are derived
from the same integration site. To avoid this problem, we constructed
a Moloney murine leukemia virus (Mo-MuLV)-based retroviral vector
which carries the
loxP sequence in each of the 5' and 3' long
terminal repeats (LTRs). A previous study by Masuda et al. (
19)
indicated that proviral DNA of the
loxP-carrying vector could
be excised by Cre-mediated homologous recombination, leaving
a solo LTR. It was also shown that inverse PCR taking advantage
of the solo LTR allowed simultaneous cloning of the upstream
and downstream flanking sequences in a single plasmid (
19).
In this study, we examined whether this method, termed solo
LTR inverse PCR (SLIP), could be used to analyze polyclonal
cell populations for proviral integration sites. The SLIP method
was performed on five independent polyclonal populations of
the vector-transduced cells representing a total of 151 integration
events, and host DNA sequences corresponding to 38 proviral
integration sites were successfully determined. The unique ability
of the SLIP method to simultaneously characterize the upstream
and downstream cellular flanking sequences revealed that the
virus-host DNA junctions of more than 20% of the examined integration
sites had aberrant structures which differed from the canonical
4-bp duplication expected for Mo-MuLV integration. The results
suggested that the SLIP method is useful for characterizing
proviral integration targets, whose analysis may provide novel
insights into the mechanism of retroviral integration and its
target selection.
(Portions of this study were performed by Yi Feng Jin in partial fulfillment of the requirements for a Ph.D. degree at the Graduate School of Medicine, the University of Tokyo.)

MATERIALS AND METHODS
Vector plasmid.
The Mo-MuLV-based vector, TSN-lox, was described previously
(
19). Briefly, it carries the herpes simplex virus type 1 thymidine
kinase gene (
tk), the simian virus 40 replication origin, and
the neomycin resistance gene (
neo). It also has the
loxP sequence
in the R region of both the 5' and 3' LTRs. The LTL-lox vector
used in this study (see Fig.
1) was constructed by removing
the simian virus 40 origin and
neo from TSN-lox. For this purpose,
the TSN-lox vector plasmid was digested by
BamHI,
ClaI, and
XhoI, and the
BamHI-
XhoI,
ClaI-
BamHI, and
XhoI-
ClaI fragments
containing the 5' and 3' LTRs and the
tk gene, respectively,
were ligated.
Cell culture.
PT67 packaging cells expressing the
gag and
pol genes of Mo-MuLV
and the
env gene of 10A1 MuLV (
21) were purchased from Clontech
and grown in Dulbecco's modified Eagle's medium supplemented
with 10% fetal calf serum. The
tk- Rat2 cells (
41) were also
grown in Dulbecco's modified Eagle's medium supplemented with
10% fetal calf serum. For selection of
tk+ and
tk- cells, cells
were grown in the presence of hypoxanthine-aminopterin-thymidine
(HAT) supplement (Life Technologies, Inc.) and 100 µM
bromovinyldeoxyuridine (BVdU), respectively, as described previously
(
19).
Virus.
LTL-lox vector virus was prepared by transfecting PT67 cells with the vector plasmid by the calcium phosphate precipitation method (44) using a CellPhect transfection kit (Pharmacia). Two days later, culture supernatants were harvested, filtered, and stored at -80°C. A Cre-expressing adenoviral vector, Adex1CAN-Cre (12, 13), was provided by Izumu Saito (Institute of Medical Science, The University of Tokyo) and propagated as described previously (26). For Adex1CAN-Cre infection, cells were added to the virus-containing fluid and incubated for 1 h at 37°C in a CO2 incubator for adsorption. Then the virus fluid was removed and replaced with fresh culture medium.
DNA analysis.
Chromosomal DNA (0.5 to 2 µg) was digested with Tsp509I, treated with T4 DNA ligase, and ethanol precipitated. The dried DNA pellet was used as a template for inverse PCR as described previously (19). All of the reagents for PCR were obtained from PE Biosystems. For the first-round reaction, a 50-µl reaction mixture was prepared by adding 38.5 µl of sterile distilled water, 5 µl of 10x PCR buffer, 1 µl each of dATP, dCTP, dGTP, and dTTP (final concentration, 1 mM each), 1 µl each of LTR-specific oligonucleotide primers (5'-ACTTGTGGTCTCGCTGTTCCTTGGG-3' and 5'-ATCTGTTCCTGACCTTGATCTGAA C-3'; final concentration, 33 pM each), and 0.5 µl of AmpliTaq DNA polymerase (5 U/µl). Then, 25 cycles of PCR were carried out, with each cycle consisting of 94°C for 1 min, 55°C for 1 min, and 72°C for 2 min. Using 2 µl of the first-round PCR product as a template, 30 cycles of second-round PCR were carried with another set of primers (5'-GTCTCCTCTGAGTGATTGAC-3' and 5'-GTTACTTAAGCTAGCTTGCC-3'). Purified PCR products were cloned in pT7Blue (Novagen) using a Perfectly Blunt Cloning Kit (Novagen) and transformed into NovaBlue Escherichia coli (Novagen), which allowed the blue-white screening by
-complementation (18). The nucleotide sequence of the cloned DNA was determined with an ABI Prism cycle sequencing kit (PE Biosystems) and a genetic analyzer (model 310; PE Biosystems). For PCR amplification of uninfected Rat2 cell DNA corresponding to proviral integration target sites, the following sets of oligonucleotides were used: 5'-CTTGCAACGCTAAGGTCGTT-3' and 5'-TTCCTTACAAAGGGGCTTCA-3' for the integration target in clone 1-32; 5'-GCCAGCCTGGTCTACATAGTG-3' and 5'-ACAGAAAACGGTTGGAGGTG-3' for clone 2-21; 5'-ATTGTGAGCAATGGTGAGCA-3' and 5'-TTGTTAACTTTTCTTG-3' for clone 3-5; 5'-TTCTATCAGTTTGCCTATAG-3' and 5'-CATCGAGAGGTAAAATACTC-3' for clone 3-19; 5'-GTGGCCACCTCGTGTAGTTT-3' and 5'-CCCAACAGACCTAATGAAAGAA-3' for clone 4-5; 5'-CAGTATGGCTGGAGACACGG-3' and 5'-GCTTCCTTCTTGTGTCGCTT-3' for clone 5-6; and 5'-AGAGAGGGTGGCTGAG-3' and 5'-AAACTGGTCTCCGAATCCTG-3' for clone 5-H1-6. Then, amplified fragments were cloned and sequenced as described above.
Sequence analysis.
Database analysis of the obtained sequences was performed by using the BLAST homology search program (1).

RESULTS
Construction of proviral integration site libraries by SLIP.
A general procedure for the SLIP method is depicted in Fig.
1. To construct a proviral integration site library,
tk- Rat2
cells seeded at a density of 10
5 cells per well in a six-well
plate were infected with LTL-lox vector at a low multiplicity
of infection so that multiple integration events in each cell
could be avoided. Since LTL-lox carries the herpes simplex virus
type 1
tk gene, the cells successfully transduced with the vector
were obtained by 2 weeks of HAT selection. Five independent
transduction experiments generated 23, 30, 33, 20, and 45 HAT-resistant
colonies, and the colonies in each well were trypsinized and
collected to make five respective pooled cultures designated
as pools 1 through 5 (Table
1). Without further passage, cells
of each pool were seeded at a density of 5
x 10
5 cells per 60-mm
dish and the next day they were infected with adenoviral vector
Adex1CAN-Cre (multiplicity of infection, 10), which expresses
Cre recombinase (
12,
13). A portion of the cells from pool 5
were passaged once or five times every 3 days under HAT selection
and then infected with Adex1CAN-Cre to generate pools 5-H1 and
5-H5, respectively (Fig.
2A). As demonstrated previously (
19),
it was expected that Cre-
loxP DNA recombination would excise
the
tk-bearing vector proviral DNA (Fig.
1). Therefore, BVdU
(100 µM), which is toxic to
tk-expressing cells, was added
to the culture medium 48 h after Adex1CAN-Cre infection. The
BVdU-resistant cells in each dish were harvested, and their
chromosomal DNA was extracted. A part of the cells derived from
pool 5 were passaged once or five times every 3 days in the
presence of BVdU to generate pools 5-B1 and 5-B5, respectively,
and then their DNA was extracted (Fig.
2A). The cellular DNA
(0.5 to 2 µg) was digested with
Tsp509I, a 4-base cutter
whose recognition site does not exist in the LTR, and treated
with T4 DNA ligase to circularize restriction fragments (Fig.
1). Then, nested inverse PCR with two sets of LTR-specific primers
was carried out, and the products were cloned in pT7Blue and
transformed into
E. coli (NovaBlue) under conditions that several
hundred colonies were formed on a 100-mm agar plate (Fig.
1).
The

-complementation indicated that more than 90% of the colonies
had a plasmid with an insert fragment. As a control, DNA extracted
from untransduced Rat2 cells was also subjected to the same
procedure.
Analysis of the integration site libraries.
Of 479 white colonies on the agar plate of the integration site
library for pool 1, 30 white colonies were randomly selected,
and the plasmids extracted from these clones were used for nucleotide
sequencing (Table
1). Similarly, 38, 44, and 30 clones derived
from pools 2, 3, and 4 were sequenced. As for pool 5 and its
derivatives (Fig.
2A), a total of 92 clones were sequenced (Table
1). Three clones of pool 1 had a primer- or vector-derived sequence
as the insert and were most likely generated by an artifact.
One clone of pool 2 had a sequence homologous to N-tropic ecotropic
mouse endogenous retrovirus envelope gene (
25) (Table
1). The
same endogenous viral sequence was obtained when a SLIP library
of uninfected Rat2 cells was analyzed. It was most likely that
the PCR primers could cross-hybridize with the LTR of the endogenous
retrovirus. The clones that carried an insert generated by those
artifacts were discarded, and the remaining clones were defined
as representatives of proper viral integration events. Some
of the clones satisfying the criteria contained the same sequence,
indicating that they were sister clones corresponding to same
integration target. Thus, 27 clones derived from pool 1 were
finally categorized to six integration sites (Table
1 and Fig.
3). Similarly, clones derived from pool 2 through 5 defined
8, 8, 3, and 13 integration sites, respectively (Table
1 and
Fig.
3). Collectively, 38 integration sites of 151 integration
events were identified (Table
1).
Comparison of the results obtained by SLIP analysis of pool
5 and its derivative pools suggested that prolonged HAT selection,
but not BVdU selection, decreased the clonal diversity of the
culture (Fig.
2B).
Aberrant sequence duplication was found at the virus-host DNA junction of more than 20% of the integration sites.
Figure 3 shows the nucleotide sequences of the 38 integration sites. A major advantage of the SLIP method was that both the upstream and downstream cellular flanking sequences were determined simultaneously for individual integration sites of the cells in polyclonal population. It is generally believed that integration of Mo-MuLV generates a 4-bp duplication of the target DNA sequence at the junction of the provirus and flanking regions (38, 42). Consistently, 30 of 38 integration sites examined in this study had a 4-bp duplication (Fig. 3). In contrast, the other eight integration sites, amounting to more than 20% of the examined sites, had aberrant structures at the virus-host DNA junctions. Of these eight cases, six had a 5-bp duplication at the junction (Fig. 4A). To determine nucleotide sequences of the original integration targets, genomic DNA of uninfected Rat2 cells was amplified by PCR and sequenced, except for clone B5-5 of pool 5, whose target site was immediately flanked by a repetitive motif. The results indicated that the five duplicated nucleotides were derived from rat DNA in all cases examined. Clone 19 of pool 3 had 5'-AATCC-3' and 5'-TTTCC-3' at the upstream and downstream junctions, respectively (Fig. 4B). PCR amplification and nucleotide sequencing of this region in uninfected Rat2 chromosomes revealed that the original sequence at the integration target was 5'-AATCCAA-3' (Fig. 4B). As for clone 6 of pool 5, four molecular clones were obtained. Two of them had 5'-CTAG-3' and 5'-TTAG-3', and the other two had 5'-CTAA-3' and 5'-CTAG-3' at the upstream and downstream junctions, respectively (Fig. 4C). The original rat genomic sequence at this site was 5'-CTAG-3' (Fig. 4C).
Other molecular characteristics found at integration targets.
Homology search analysis was carried out on the isolated integration
target sequences with the BLAST software (
1). The results indicated
that more than 45% of the integration targets were localized
within or in the vicinity of repetitive sequences such as B
family (Fig.
5), Alu-like sequence, and L1 (Table
2). Integration
targets of clone 21 of pool 1 and clones 24 and B5-5 of pool
5 were found in the region of simple-patterned repetitive motifs
such as (G
1-2T
1-2)
n, (CATA)
n, and (C
1-3T
1-3)
n, respectively
(Fig.
3). The BLAST search did not unequivocally reveal homology
between cloned integration targets and known functional genes.
The average GC content of the target regions shown in Fig.
3 was 42.6% and was comparable to the value for the rat genome
(41.8%). However, the frequency of each nucleotide varied from
position to position, and the schematic box plot analysis indicated
that the AT frequencies at positions -2 and +2 and the GC frequency
at position +27 were higher than those at other positions (Fig.
6).

DISCUSSION
Previous PCR-based methods, such as inverse PCR and vectorette
PCR, are usually used to amplify either the upstream or downstream
cellular flanking sequence at proviral integration sites, but
not both at the same time. Therefore, when a polyclonal population
of cells harboring provirus at different chromosomal positions
is analyzed, it is difficult to determine which upstream and
downstream sequences are derived from the same integration site.
In contrast, the SLIP method enables simultaneous isolation
of upstream and downstream cellular flanking sequences of individual
proviral integration sites and it was used in the previous study
to analyze monoclonal cell populations for their proviral integration
targets (
19). In this study, it was demonstrated that SLIP is
also useful for analyzing polyclonal cell populations.
By analysis of five cell populations representing a total of 151 integration events of the Mo-MuLV-based LTL-lox vector, nucleotide sequences of 38 independent integration targets were determined. Due to the unique ability of the SLIP method to amplify the upstream and downstream flanking sequences simultaneously, we were able to directly compare the 5' and 3' virus-host DNA junctions of these integration sites. As shown in Fig. 7A, it is thought that Mo-MuLV generates duplication of 4-bp host sequences at the virus-host DNA junctions (38, 42). Thirty of 38 integration sites examined in this study were compatible with this canonical structure. Although no strong consensus sequence was found among those 4-bp duplications, the results appeared to be consistent with the previous study showing that the middle two positions of the 4-bp direct repeat are preferentially occupied by AA, TT, or AT dinucleotides (31). Interestingly, as many as eight integration sites, amounting to more than 20% of the obtained clones, had atypical virus-host DNA junction structures. Of these aberrant clones, six had 5-bp duplication at the junctions. Analysis of original rat DNA sequences corresponding to these integration targets suggested that the 5-bp duplications had been generated by introduction of staggered cuts in the host DNA at positions 5 bp apart from each other (Fig. 7B). Although a 4-bp duplication associated with incomplete removal of a viral terminal nucleotide (Fig. 7C and D) (11, 17, 19, 39) could explain 2 of the 5 bp duplications (clones 1-32 and clone 4-5), that does not appear to be the case. Clone 3-19 had 5'-AATCC-3' and 5'-TTTCC-3' at the upstream and downstream junctions, respectively. Since the original sequence of this site in the rat genome was determined to be 5'-AATCCAA-3', it is possible that this aberrant junction structure was generated by a 3-bp duplication (5'-TCC-3') combined with failure of removal of the 3' terminal dinucleotide of the unintegrated proviral DNA (Fig. 7E). As for clone 6 of pool 5, four molecular clones with different sequences were obtained. Two of them had 5'-CTAG-3' and 5'-TTAG-3', and the other two had 5'-CTAA-3' and 5'-CTAG-3' at the upstream and downstream junctions, respectively. The original rat genomic sequence of this site was 5'-CTAG-3'. It is possible that a base-pair mismatch caused by incomplete removal of the terminal nucleotide was retained at each end of the integrated provirus and that DNA replication of the region took place before the mismatches were repaired (Fig. 7F). Following cell division, two types of daughter cells, carrying different junction structures may have been generated. Previous studies on AKR MuLV and avian leukemia and sarcoma virus-based vectors have described unexpected virus-host DNA junction structures at the integration target revealing microhomologies with viral LTR ends (23, 43). However, similar findings were not obtained for eight aberrant cases found in this study. It has previously been shown that noncanonical virus-host DNA junction structures could be generated for Mo-MuLV with mutations at the LTR terminus and AKR MuLV (6, 7, 43). It has also been shown that mutation in conserved amino acids in the catalytic domain of the human immunodeficiency virus type 1 IN impaired IN-mediated proviral integration, causing aberrant virus-host DNA junction structures (8). In contrast, the vector virus used in this study had a Mo-MuLV LTR with the intact terminal structure and was produced by PT67 packaging cells, which express wild-type Mo-MuLV IN (21). Therefore, it is possible that the normal process of Mo-MuLV proviral integration is intrinsically more error-prone than generally thought.
Nucleotide sequence analysis showed that as many as 47% of the
integration targets were found within or near a repetitive sequence.
Since it is estimated that about 40% of a mammalian genome consists
of repetitive sequences, the results may not necessarily indicate
that repetitive sequences are preferred targets for proviral
integration. A previous study on human immunodeficiency virus
type 1 also revealed no strong biases either for or against
integration near repetitive sequences in the human genome (
4).
In this study, several integration targets, such as clone 21
of pool 1 and clones 24 and B5-5 of pool 5, consisted of repetition
of simple motifs, such as (G
1-2T
1-2)
n, (CATA)
n, and (C
1-3T
1-3)
n,
respectively. Further studies are necessary to examine whether
repetition of these simple motifs plays a role in constituting
a preferred structure for proviral integration. Analysis of
the integration target sequences also showed that the AT frequencies
at positions -2 and +2 were higher than those at other positions.
The results appear to be compatible with the previous data on
human T-cell leukemia virus type 1 integration targets (
16).
The GC frequency at position +27 was also high. Further studies
are necessary to examine its biological significance.
The SLIP method used in the present study depended on selection for transgene (tk) expression. Therefore, the collected integration sites may represent not only preferred integration targets but also favorable contexts for proviral expression. In addition, prolonged HAT selection appeared to decrease clonal diversity of the pooled culture, possibly causing different levels of effects on cell proliferation of individual clones. It should also be mentioned that the fraction of successfully cloned sites was relatively small (38 out of 151 integration events) and that some sites were cloned multiple times. Several factors, such as the biases for and against growth of certain cell clones and different efficiencies in PCR amplification of various sites, may have been responsible. To solve these problems, efforts are being made to improve the protocol of the SLIP method. For example, a DNA clone for Mo-MuLV bearing loxP in the R region of the 5' and 3' LTRs was constructed, and our preliminary data indicate that the recombinant virus could be propagated without losing loxP (data not shown). Using this virus, it may be possible to carry out the SLIP method without having to depend on proviral expression.
Retroviral vectors are thought to be useful tools for gene therapy. However, additional studies on the target specificity of proviral integration would be necessary for addressing the safety issue of retrovirus-mediated gene therapy (10). Characterization of integration targets by using the SLIP method may be effective for this purpose and may provide useful insights into the mechanism for retroviral integration and its target selection.

ACKNOWLEDGMENTS
We thank Izumu Saito for the Adex1 CAN-Cre vector, Hiroko Igarashi
for technical assistance, and Etsuko Suzuki and Yuko Matsushita
(Graduate School of Medicine, The University of Tokyo) as well
as Saki Yachuuda and Yuki Shinozaki (Dokkyo University, School
of Medicine) for secretarial work. We also thank Takao Masuda
(Tokyo Medical and Dental University) for useful discussion.

FOOTNOTES
* Corresponding author. Mailing address: Department of Microbiology, Dokkyo University School of Medicine, Tochigi 321-0293, Japan. Phone: 81-282-87-2131. Fax: 81-282-86-5616. E-mail:
m-masuda{at}dokkyomed.ac.jp.


REFERENCES
1
- Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.[Abstract/Free Full Text]
2
- Arnold, C., and I. J. Hodgson. 1991. Vectorette PCR: a novel approach to genomic walking. PCR Methods Appl. 1:39-42.[Medline]
3
- Berger, N., A. E. Heller, K. D. Stormann, and E. Pfaff. 2001. Characterization of chimeric enzymes between caprine arthritis-encephalitis virus, maedi-visna virus and human immunodeficiency virus type 1 integrases expressed in Escherichia coli. J. Gen. Virol. 82:139-148.[Abstract/Free Full Text]
4
- Carteau, S., C. Hoffmann, and F. Bushman. 1998. Chromosome structure and human immunodeficiency virus type 1 cDNA integration: centromeric alphoid repeats are a disfavored target. J. Virol. 72:4005-4014.[Abstract/Free Full Text]
5
- Chou, K. S., A. Okayama, I. J. Su, T. H. Lee, and M. Essex. 1996. Preferred nucleotide sequence at the integration target site of human T-cell leukemia virus type I from patients with adult T-cell leukemia. Int. J. Cancer 65:20-24.[CrossRef][Medline]
6
- Colicelli, J., and S. P. Goff. 1988. Isolation of an integrated provirus of Moloney murine leukemia virus with long terminal repeats in inverted orientation: integration utilizing two U3 sequences. J. Virol. 62:633-636.[Abstract/Free Full Text]
7
- Colicelli, J., and S. P. Goff. 1985. Mutants and pseudorevertants of Moloney murine leukemia virus with alterations at the integration site. Cell 42:573-580.[CrossRef][Medline]
8
- Gaur, M., and A. D. Leavitt. 1998. Mutations in the human immunodeficiency virus type 1 integrase D,D(35)E motif do not eliminate provirus formation. J. Virol. 72:4678-4685.[Abstract/Free Full Text]
9
- Goodenow, M. M., and W. S. Hayward. 1987. 5' Long terminal repeats of myc-associated proviruses appear structurally intact but are functionally impaired in tumors induced by avian leukosis viruses. J. Virol. 61:2489-2498.[Abstract/Free Full Text]
10
- Holmes-Son, M. L., R. S. Appa, and S. A. Chow. 2001. Molecular genetics and target site specificity of retroviral integration. Adv. Genet. 43:33-69.[Medline]
11
- Ju, G., and A. M. Skalka. 1980. Nucleotide sequence analysis of the long terminal repeat (LTR) of avian retroviruses: structural similarities with transposable elements. Cell 22:379-386.[CrossRef][Medline]
12
- Kanegae, Y., G. Lee, Y. Sato, M. Tanaka, M. Nakai, T. Sakaki, S. Sugano, and I. Saito. 1995. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res. 23:3816-3821.[Abstract/Free Full Text]
13
- Kanegae, Y., K. Takamori, Y. Sato, G. Lee, M. Nakai, and I. Saito. 1996. Efficient gene activation system on mammalian cell chromosomes using recombinant adenovirus producing Cre recombinase. Gene 181:207-212.[CrossRef][Medline]
14
- Katz, R. A., K. Gravuer, and A. M. Skalka. 1998. A preferred target DNA structure for retroviral integrase in vitro. J. Biol. Chem. 273:24190-24195.[Abstract/Free Full Text]
15
- Kitamura, Y., Y. M. Lee, and J. M. Coffin. 1992. Nonrandom integration of retroviral DNA in vitro: effect of CpG methylation. Proc. Natl. Acad. Sci. USA 89:5532-5536.[Abstract/Free Full Text]
16
- Leclercq, I., F. Mortreux, M. Cavrois, A. Leroy, A. Gessain, S. Wain-Hobson, and E. Wattel. 2000. Host sequences flanking the human T-cell leukemia virus type 1 provirus in vivo. J. Virol. 74:2305-2312.[Abstract/Free Full Text]
17
- Majors, J. E., and H. E. Varmus. 1981. Nucleotide sequences at host-proviral junctions for mouse mammary tumour virus. Nature 289:253-258.[CrossRef][Medline]
18
- Maniatis, T., J. Sambrook, and E. F. Fritsch. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
19
- Masuda, M., H. Igarashi, M. Kano, and H. Yoshikura. 1998. Effects of procollagen C-proteinase enhancer protein on the growth of cultured rat fibroblasts revealed by an excisable retroviral vector. Cell Growth Differ. 9:381-391.[Abstract]
20
- Mielke, C., K. Maass, M. Tummler, and J. Bode. 1996. Anatomy of highly expressing chromosomal sites targeted by retroviral vectors. Biochemistry 35:2239-2252.[CrossRef][Medline]
21
- Miller, A. D., and F. Chen. 1996. Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry. J. Virol. 70:5564-5571.[Abstract/Free Full Text]
22
- Milot, E., A. Belmaaza, E. Rassart, and P. Chartrand. 1994. Association of a host DNA structure with retroviral integration sites in chromosomal DNA. Virology 201:408-412.[CrossRef][Medline]
23
- Moreau, K., C. Torne-Celer, C. Faure, G. Verdier, and C. Ronfort. 2000. In vivo retroviral integration: fidelity to size of the host DNA duplication might be reduced when integration occurs near sequences homologous to LTR ends. Virology 278:133-136.[CrossRef][Medline]
24
- Muller, H. P., and H. E. Varmus. 1994. DNA bending creates favored sites for retroviral integration: an explanation for preferred insertion sites in nucleosomes. EMBO J. 13:4704-4714.[Medline]
25
- Portis, J. L., S. Perryman, and F. J. McAtee. 1991. The R-U5-5' leader sequence of neurovirulent wild mouse retrovirus contains an element controlling the incubation period of neurodegenerative disease. J. Virol. 65:1877-1883.[Abstract/Free Full Text]
26
- Precious, B., and W. C. Russell. 1985. Growth, purification, and titration of adenoviruses, p. 193-206. In B. W. J. Mahy (ed.) Virology: a practical approach. IRL Press, Oxford, United Kingdom.
27
- Pruss, D., F. D. Bushman, and A. P. Wolffe. 1994. Human immunodeficiency virus integrase directs integration to sites of severe DNA distortion within the nucleosome core. Proc. Natl. Acad. Sci. USA 91:5913-5917.[Abstract/Free Full Text]
28
- Pruss, D., R. Reeves, F. D. Bushman, and A. P. Wolffe. 1994. The influence of DNA and nucleosome structure on integration events directed by HIV integrase. J. Biol. Chem. 269:25031-25041.[Abstract/Free Full Text]
29
- Pryciak, P. M., H. P. Muller, and H. E. Varmus. 1992. Simian virus 40 minichromosomes as targets for retroviral integration in vivo. Proc. Natl. Acad. Sci. USA 89:9237-9241.[Abstract/Free Full Text]
30
- Pryciak, P. M., A. Sil, and H. E. Varmus. 1992. Retroviral integration into minichromosomes in vitro. EMBO J. 11:291-303.[Medline]
31
- Pryciak, P. M., and H. E. Varmus. 1992. Nucleosomes, DNA-binding proteins, and DNA sequence modulate retroviral integration target site selection. Cell 69:769-780.[CrossRef][Medline]
32
- Robinson, H. L., and G. C. Gagnon. 1986. Patterns of proviral insertion and deletion in avian leukosis virus-induced lymphomas. J. Virol. 57:28-36.[Abstract/Free Full Text]
33
- Rohdewohld, H., H. Weiher, W. Reik, R. Jaenisch, and M. Breindl. 1987. Retrovirus integration and chromatin structure: Moloney murine leukemia proviral integration sites map near DNase I-hypersensitive sites. J. Virol. 61:336-343.[Abstract/Free Full Text]
34
- Rynditch, A. V., S. Zoubak, L. Tsyba, N. Tryapitsina-Guley, and G. Bernardi. 1998. The regional integration of retroviral sequences into the mosaic genomes of mammals. Gene 222:1-16.[CrossRef][Medline]
35
- Scherdin, U., K. Rhodes, and M. Breindl. 1990. Transcriptionally active genome regions are preferred targets for retrovirus integration. J. Virol. 64:907-912.[Abstract/Free Full Text]
36
- Shibagaki, Y., and S. A. Chow. 1997. Central core domain of retroviral integrase is responsible for target site selection. J. Biol. Chem. 272:8361-8369.[Abstract/Free Full Text]
37
- Shih, C. C., J. P. Stoye, and J. M. Coffin. 1988. Highly preferred targets for retrovirus integration. Cell 53:531-537.[CrossRef][Medline]
38
- Shoemaker, C., S. Goff, E. Gilboa, M. Paskind, S. W. Mitra, and D. Baltimore. 1980. Structure of a cloned circular Moloney murine leukemia virus DNA molecule containing an inverted segment: implications for retrovirus integration. Proc. Natl. Acad. Sci. USA 77:3932-3936.[Abstract/Free Full Text]
39
- Shoemaker, C., J. Hoffman, S. P. Goff, and D. Baltimore. 1981. Intramolecular integration within Moloney murine leukemia virus DNA. J. Virol. 40:164-172.[Abstract/Free Full Text]
40
- Silver, J., and V. Keerikatte. 1989. Novel use of polymerase chain reaction to amplify cellular DNA adjacent to an integrated provirus. J. Virol. 63:1924-1928.[Abstract/Free Full Text]
41
- Topp, W. C. 1981. Normal rat cell lines deficient in nuclear thymidine kinase. Virology 113:408-411.[CrossRef][Medline]
42
- van Beveren, C., J. G. Goddard, A. Berns, and I. M. Verma. 1980. Structure of Moloney murine leukemia viral DNA: nucleotide sequence of the 5' long terminal repeat and adjacent cellular sequences. Proc. Natl. Acad. Sci. USA 77:3307-3311.[Abstract/Free Full Text]
43
- van Beveren, C., E. Rands, S. K. Chattopadhyay, D. R. Lowy, and I. M. Verma. 1982. Long terminal repeat of murine retroviral DNAs: sequence analysis, host-proviral junctions, and preintegration site. J. Virol. 41:542-556.[Abstract/Free Full Text]
44
- van der Eb, A. J., and F. L. Graham. 1980. Assay of transforming activity of tumor virus DNA. Methods Enzymol. 65:826-839.[Medline]
45
- Vijaya, S., D. L. Steffen, and H. L. Robinson. 1986. Acceptor sites for retroviral integrations map near DNase I-hypersensitive sites in chromatin. J. Virol. 60:683-692.[Abstract/Free Full Text]
46
- Weidhaas, J. B., E. L. Angelichio, S. Fenner, and J. M. Coffin. 2000. Relationship between retroviral DNA integration and gene expression. J. Virol. 74:8382-8389.[Abstract/Free Full Text]
47
- Withers-Ward, E. S., Y. Kitamura, J. P. Barnes, and J. M. Coffin. 1994. Distribution of targets for avian retrovirus DNA integration in vivo. Genes Dev. 8:1473-1487.[Abstract/Free Full Text]
Journal of Virology, June 2002, p. 5540-5547, Vol. 76, No. 11
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.11.5540-5547.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Nielsen, A. A., Sorensen, A. B., Schmidt, J., Pedersen, F. S.
(2005). Analysis of Wild-Type and Mutant SL3-3 Murine Leukemia Virus Insertions in the c-myc Promoter during Lymphomagenesis Reveals Target Site Hot Spots, Virus-Dependent Patterns, and Frequent Error-Prone Gap Repair. J. Virol.
79: 67-78
[Abstract]
[Full Text]